NCT04252729 is a NA clinical trial of Psychotherapy in Syncope, sponsored by Mauricio Ibrahim Scanavacca.

Who is sponsoring NCT04252729?

NCT04252729 is sponsored by Mauricio Ibrahim Scanavacca.

What drugs are being tested in NCT04252729?

Interventions in NCT04252729: Psychotherapy.

Is NCT04252729 still recruiting?

NCT04252729 is currently completed. Last updated 5 February 2020.

Last reviewed 2020-02-05 · How we verify

NCT04252729

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Psychotherapy on Quality of Life and Recurrence of Events in Patients With Recurrent Vasovagal Syncope: A Randomized Pilot Study

Completed NA Last updated 5 February 2020

What this trial tests

NA trial testing Psychotherapy in Syncope in 10 participants. Completed in 23 August 2018.

Timeline

27 July 2017

Primary endpoint
3 August 2018

23 August 2018

Quick facts

Lead sponsor	Mauricio Ibrahim Scanavacca
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	10
Start date	27 July 2017
Primary completion	3 August 2018
Estimated completion	23 August 2018
Sites	1 location across Brazil

Drugs / interventions tested

Psychotherapy

Conditions studied

Syncope — all drugs for Syncope →

Sponsor

Mauricio Ibrahim Scanavacca

Who can join

18 and older, any sex, with Syncope. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Recurrent vasovagal syncope although presenting a benign prognosis in terms of survival, is associated with significant impairment of quality of life. The impaired emotional status is also related to the recurrence of the events, closing a negative cycle for the evolution of the disease. This study aims to evaluate the effect of psychotherapy on the quality of life and in the number of syncope and pre-syncope events during one year of follow-up of patients with recurrent vasovagal syncope.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of psychotherapy on recurrence of events and quality of life in patients with vasovagal syncope.
de Barros E Silva RLA, Volich RM, de Barros E Silva PGM, da Costa Darrieux FC, et al · · 2022 · cited 5× · PMID 35388029 · DOI 10.1038/s41598-022-09513-1

Verify or expand the search:

Other trials of Psychotherapy

Trials testing the same drug.

NCT06827054 — Psilocybin With Psychotherapy for Improving Chronic Pain in Cancer Patients Requiring Opioids · Phase 2 · not yet recruiting
NCT07336238 — Group Retreat Psilocybin Therapy for the Treatment of Anxiety and Depression in Patients With Metastatic Solid Tumors or · Phase 2 · recruiting
NCT07507370 — CARED : A Novel Rapid Treatment Paradigm for Depression · NA · not yet recruiting
NCT07250893 — Resolving Early Life Stress: Psychotherapy Outcomes and Neurobiology in Complex Depression · NA · recruiting
NCT06353282 — MDMA-Assisted Psychotherapy for Treatment Resistant PTSD in Adolescents · Phase 2 · withdrawn

Other recruiting trials for Syncope

Currently open trials in the same condition.

NCT05896592 — Comparison of the Efficacy and Safety of Cardioneuroablation to Permanent Pacing in Patients With an Implanted Pacemaker · NA · recruiting
NCT06526884 — Quasi-Randomized Evaluation of the UCLA Next Day Clinic (NDC) · NA · active not recruiting
NCT06503653 — Creation of a Syncope Channel for Patients Admitted to the Emergency Department for Loss of Consciousness and Not Hospit · NA · active not recruiting
NCT06288633 — Cardioneuroablation for Bradyarrhythmia · NA · recruiting
NCT06087497 — The Z Stitch Early Bed Rest Assessment Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04252729 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mauricio Ibrahim Scanavacca
Last refreshed: 5 February 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04252729.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing